Word

ANKET

Status

Registered

Status Code

700

Status Date

Tuesday, January 17, 2023

Serial Number

97085429

Registration Number

6952905

Registration Date

Tuesday, January 17, 2023

Mark Type

4000

Filing Date

Thursday, October 21, 2021

Published for Opposition

Tuesday, November 1, 2022

Trademark Owner History

INNATE PHARMA - Original Registrant

Classifications

5 Pharmaceuticals, medical, biological or biochemical preparations, substances for the treatment of diseases, as well as preparations for medical treatments, in particular, antibodies and derivatives being monoclonal antibodies, bispecific antibodies, multispecific antibodies, antibody fragments, single-chain variable fragments, di-scFv or light and heavy chains of antibodies for medical purposes, bifunctional or multifunctional proteins being T-cell engagers or NK cell engagers for medical purposes with binding affinity to immune cells, in particular NK cells, and other reagents for the diagnosis, prevention, monitoring and treatment of diseases, in particular cancers, infectious diseases, inflammatory diseases, and other immune pathologies

1 Chemical or biotechnological products for industry and science, namely, polypeptides and proteins; biological preparations, in particular antibodies in the nature of monoclonal antibodies, bispecific antibodies or multifunctional antibodies, antibody derivatives in the nature of antibody fragments, single-chain variable fragments, di-scFv, light and heavy chains of antibodies, binding proteins and peptides having a binding affinity to immune cells in the nature of T-cell engagers or NK-cell engagers, for laboratory and experimental purposes, in particular for conducting experimental tests other than for medical use; Biochemicals, namely, polypeptides for in vitro research use

42 Scientific and technological services, namely, research and development in scientific and medical matters, in particular in the field of immunotherapy; scientific and technological services, namely, scientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory research, analysis, evaluation, development and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodies, antibody derivatives, proteins, or other agents for activating or modulating natural and adaptive immunity

Trademark Events

Jan 17, 2023

Notice Of Registration Confirmation Emailed

Jan 17, 2023

Registered-Principal Register

Nov 1, 2022

Official Gazette Publication Confirmation E-Mailed

Nov 1, 2022

Published For Opposition

Oct 12, 2022

Notification Of Notice Of Publication E-Mailed

Sep 27, 2022

Approved For Pub - Principal Register

Sep 24, 2022

Teas/Email Correspondence Entered

Sep 23, 2022

Correspondence Received In Law Office

Sep 23, 2022

Teas Response To Office Action Received

Aug 8, 2022

Notification Of Non-Final Action E-Mailed

Aug 8, 2022

Non-Final Action E-Mailed

Aug 8, 2022

Non-Final Action Written

Jul 28, 2022

Assigned To Examiner

Nov 7, 2021

New Application Office Supplied Data Entered In Tram

Oct 25, 2021

New Application Entered In Tram